Page last updated: 2024-11-05

trioxsalen and Skin Diseases

trioxsalen has been researched along with Skin Diseases in 5 studies

Trioxsalen: Pigmenting photosensitizing agent obtained from several plants, mainly Psoralea corylifolia. It is administered either topically or orally in conjunction with ultraviolet light in the treatment of vitiligo.
lactone : Any cyclic carboxylic ester containing a 1-oxacycloalkan-2-one structure, or an analogue having unsaturation or heteroatoms replacing one or more carbon atoms of the ring.
antipsoriatic : A drug used to treat psoriasis.
trioxsalen : 7H-Furo[3,2-g]chromen-7-one in which positions 2, 5, and 9 are substituted by methyl groups. Like other psoralens, trioxsalen causes photosensitization of the skin. It is administered orally in conjunction with UV-A for phototherapy treatment of vitiligo. After photoactivation it creates interstrand cross-links in DNA, inhibiting DNA synthesis and cell division, and can lead to cell injury; recovery from the cell injury may be followed by increased melanisation of the epidermis.

Skin Diseases: Diseases involving the DERMIS or EPIDERMIS.

Research Excerpts

ExcerptRelevanceReference
"DNA of Xeroderma pigmentosum cells was crosslinked in vivo with trioxsalen and long wave length ultraviolet light and the cells were cultured in the presence of labelled thymidine for one hour."3.67Identification of the short dispersed repetitive DNA sequences isolated from the zones of initiation of DNA synthesis in human cells as Alu-elements. ( Altmann, H; Anachkova, B; Russev, G, 1985)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19904 (80.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kano, Y1
Fujiwara, Y1
Shephard, SE1
Panizzon, RG1
Carter, DM1
Pan, M1
Gaynor, A1
McGuire, JS1
Sibrack, L1
Anachkova, B1
Russev, G1
Altmann, H1
Hönigsmann, H1

Reviews

1 review available for trioxsalen and Skin Diseases

ArticleYear
Psoralen photochemotherapy--mechanisms, drugs, toxicity.
    Current problems in dermatology, 1986, Volume: 15

    Topics: DNA; Erythema; Furocoumarins; Humans; Methoxsalen; Neoplasms, Radiation-Induced; Photosensitivity Di

1986

Other Studies

4 other studies available for trioxsalen and Skin Diseases

ArticleYear
Dyskeratosis congenita: survival, sister-chromatid exchange and repair following treatments with crosslinking agents.
    Mutation research, 1982, Volume: 103, Issue:3-6

    Topics: Cell Survival; Cells, Cultured; Cross-Linking Reagents; Crossing Over, Genetic; Diagnosis, Different

1982
Carcinogenic risk of bath PUVA in comparison to oral PUVA therapy.
    Dermatology (Basel, Switzerland), 1999, Volume: 199, Issue:2

    Topics: 5-Methoxypsoralen; Administration, Oral; Administration, Topical; Baths; DNA Adducts; Female; Humans

1999
Psoralen-DNA cross-linking photoadducts in dyskeratosis congenita: delay in excision and promotion of sister chromatid exchange.
    The Journal of investigative dermatology, 1979, Volume: 73, Issue:1

    Topics: Adolescent; Adult; Cells, Cultured; Chromatids; DNA; Dose-Response Relationship, Drug; Dose-Response

1979
Identification of the short dispersed repetitive DNA sequences isolated from the zones of initiation of DNA synthesis in human cells as Alu-elements.
    Biochemical and biophysical research communications, 1985, Apr-16, Volume: 128, Issue:1

    Topics: DNA; DNA Replication; Endonucleases; Fibroblasts; Humans; Nucleic Acid Denaturation; Nucleic Acid Hy

1985